Companies push Congress for PAHPA

January 8, 2013
by Jeffrey Bigongiari


Biotechs, drug developers, public health organizations and venture capital investors have started to push Congress to reauthorize a significant anti-bioterrorism bill as quickly as possible.

Although both chambers of the 112th Congress passed the 2006 Pandemic and All-Hazards Preparedness Act, its authorization was held up as lawmakers hoped to attach unrelated provisions to it, according to

“We’re starting all over again,” Jeff Levi, the president of the advocacy group Trust for America’s Health, said, reports.


View the full story (some sites require registration)